✦ LIBER ✦

Interferons, immunity and cancer immunoediting leading to impaired immune function in cancer patients

✍ Scribed by Brandacher, Gerald; Margreiter, Raimund; Fuchs, Dietmar

Book ID: 109955566
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 120 KB
Volume: 7
Category: Article
ISSN: 1474-1741
DOI: 10.1038/nri1961-c1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferons, immunity and cancer immunoe

Interferons, immunity and cancer immunoediting

✍ Dunn, Gavin P.; Koebel, Catherine M.; Schreiber, Robert D. 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 846 KB

Impaired cell-mediated immunity function

Impaired cell-mediated immunity function in thyroid cancer

✍ Dr. Koung-Yi Liaw; Yao Chang-Chien; Yao-Chang Chen; Jau-Shyong Deng 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views

Impaired cell-mediated immunity in patie

Impaired cell-mediated immunity in patients with cancer

✍ Dr. Joseph A. Buda; N. Suciu-Foca; Eric Blomain; Susan McManus; Keith Reemtsma 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

Immune impairment in patients with termi

Immune impairment in patients with terminal cancers: influence of cancer treatments and cytomegalovirus infection

✍ I-Hsuan Chen; Yuen-Liang Lai; Chien-Liang Wu; Yi-Fang Chang; Chen-Chung Chu; I-F 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 622 KB

Investigation and Stimulation of Immunit

Investigation and Stimulation of Immunity in Cancer Patients

✍ Moore, M 📂 Article 📅 1976 🏛 Nature Publishing Group 🌐 English ⚖ 160 KB

Serological immune response to cancer te

Serological immune response to cancer testis antigens in patients with pancreatic cancer

✍ Andreas Wadle; Boris Kubuschok; Jochen Imig; Beate Wuellner; Christine Wittig; C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 380 KB

## Abstract Serological screening approaches have allowed for the identification of a large number of potentially relevant tumor antigens in cancer patients. Within this group, cancer testis antigens represent promising targets for cancer immunotherapy, since they are widely expressed in a variety